Clinuvel Pharmaceuticals Ltd (CUV) — Capital Reinvestment Ratio
Latest as of December 2025:
0.01x
Clinuvel Pharmaceuticals Ltd (CUV) has a Capital Reinvestment Ratio of 0.01x as of December 2025, meaning it reinvests 0% of its operating cash flow (AU$12.52 Million) in capital expenditures (AU$149.47K). See Clinuvel Pharmaceuticals Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
AU$12.52 Million
AUD
Capital Expenditures
AU$149.47K
AUD
Data as of
Dec 2025
Most recent filing
Clinuvel Pharmaceuticals Ltd Capital Reinvestment Ratio (2017–2025)
This chart tracks Clinuvel Pharmaceuticals Ltd's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Clinuvel Pharmaceuticals Ltd (2017–2025)
Year-by-year Capital Reinvestment Ratio for Clinuvel Pharmaceuticals Ltd from 2017 to 2025. For live market cap and broader valuation context, see market cap of Clinuvel Pharmaceuticals Ltd.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | AU$41.10 Million | AU$298.57K | ▼ -95.2% |
| 2024 | 0.15x | AU$37.05 Million | AU$5.58 Million | ▲ +440.6% |
| 2023 | 0.03x | AU$36.91 Million | AU$1.03 Million | ▲ +155.5% |
| 2022 | 0.01x | AU$39.87 Million | AU$434.44K | ▼ -75.4% |
| 2021 | 0.04x | AU$19.26 Million | AU$854.33K | ▼ -29.2% |
| 2020 | 0.06x | AU$14.19 Million | AU$888.83K | ▲ +348.8% |
| 2019 | 0.01x | AU$18.46 Million | AU$257.62K | ▲ +117.3% |
| 2018 | 0.01x | AU$11.69 Million | AU$75.12K | ▼ -5.6% |
| 2017 | 0.01x | AU$9.92 Million | AU$67.48K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow